RPSAP68

Across TCGA pan-cancer cohorts, RPSAP68 RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated RPSAP68 data layer.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher RPSAP68 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPSAP68 expression acts as an unfavorable survival marker.

SKCM, LGG, and KIRC are the cancer types where RPSAP68 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	DFS	Tertile	II,III,IV	0.044	0.683	<.001	36	view →
LGG	OS	Tertile	All	0.101	0.909	<.001	24	view →
KIRC	DFS	Tertile	III,IV	0.250	0.753	.013	18	view →
LIHC	DFS	Tertile	All	0.054	0.553	<.001	18	view →
PRAD	DFS	Tertile	All	0.801	0.934	.039	6	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

RPSAP68–SKCM (DFS)

Open the SKCM breakdown →